Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 105 - 112 of 12091 results
Companies Are Going ‘Under the Radar’ with Climate Disclosures
June 23, 2025| News
Oregon Law Restricts Common Management Service Organization – Professional Entity Structure
June 20, 2025| Blog| Viewpoint
DOJ Civil Division Publishes Memo Outlining Trump Administration Civil Enforcement Priority Related to Health Care
June 18, 2025| Blog| Viewpoint
Webinar Recording: DOJ Enforcement in the Trump Administration: Priorities, Shifts, and Legal Impacts
June 18, 2025| Webinar| Viewpoint
AI.gov Inadvertent Disclosure Reveals President’s Plan as AI Czar Delivers First Public Comments — AI: The Washington Report
June 18, 2025| Article| Viewpoint
Practical Policies – Same Rules, Different Disclosures: Public Company DEI Reporting in a New Federal Legal Paradigm
June 17, 2025| Podcast| Viewpoint
Access to Justice Commission Reflects on First 20 years, Work Ahead
June 17, 2025| News
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|